Congratulations Dr Prof Manisha Sahay for randomising the 100th patient in The TRACK Trial Top recruiters are Hospital Tuanku Ja'afar, Seremban Hospital Raja Permaisuri Bainun, Ipoh Hospital Canselor Tuanku Muhriz Hospital Kajang University of Malaysia Medical Centre 1/3

Congratulations Sradha Kotwal! ANZSN #ANZSNASM

Fantastic opportunity at my new workplace - join us UNSW Medicine & Health

Fantastic opportunity to work on practice changing trials and big data with collaborative colleagues, and to make a global impact - join us!! Gian Luca Di Tanna Min Jun A/Prof Clare Arnott Sradha Kotwal Sunil Badve Prof Alta Schutte

Our studies found that as many as 434 million people across Asia could have chronic kidney disease and that it affects women and men differently. Urgent action in Asia is needed to prevent and manage CKD, including equitable policies that address the needs of both women and men

REDUCCTION Sradha Kotwal @dialysisbloke Sarah Coggan Stephen McDonald The George Institute for Global Health Also provides impt insights into the scale of Hawthorne effect in such evidence implementation studies

Do multifaceted interventions or care bundles reduce #Dialysis catheter related bloodstream infections? Our researchers Sradha Kotwal and team have published ✍️imp new findings from their REDUCCTION trial today in the The BMJ: ▶️bmj.com/content/377/bm…

Congratulations to Drs Majed Al Jeraisy, Mohammed Tawhari and Ahmed Shaman from KAIMRC كيمارك for enrolling their FIRST three patients in TRACK. We welcome Saudi Arabia 🇸🇦 to the TRACK trial.

Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia 🇦🇺 and Canada 🇨🇦. Kidney Medicine ➡️ bit.ly/3MD9wYl

Sharing this real-world study 🇦🇺🇨🇦showing favorable⚖️ safety🩸& effectiveness of Riva vs Warfarin across broad range of kidney fn with some imp safety data in those with greatly ⏬ kidney fn Min Jun The George Institute for Global Health UNSW Medicine & Health doi.org/10.1016/j.xkme…

The largest & most comprehensive analysis of the association between SGLT2i, blood pressure variability & cardiorenal outcomes While SGLT2i reduce BP, they have little to no effect on BP variability New #openaccess in JAHA led by Robert Fletcher ahajournals.org/doi/full/10.11…

Congratulations to Sradha Kotwal for securing NHMRC funding to test new treatments in people with #ChronicKidneyDisease at trial centres in Australia & other countries. 🔗bit.ly/3KksTE9

#ICYMI, check out this #ICESKDT study by Jeffrey Ha @jeffreyha.bsky.social and team that focused on determining the benefit–risk profile of rivaroxaban versus warfarin for atrial fibrillation in patients with #CKD. pubmed.ncbi.nlm.nih.gov/37492112/ ICES Min Jun 1/

Latest granular data on CKD trends in Australia CKD is common & increasing year on year UACR testing remains abysmally low Major opportunities for early detection & treatment to prevent cardiovascular & kidney disease Led by Min Jun in KIReports: kireports.org/article/S2468-…

Improved uptake of SGLT2i in people with CKD has the potential to substantially reduce the incidence of kidney failure in Australia Implementation now critical to realising these population level benefits Our new paper #openaccess in The Lancet Reg Health-West Pacific thelancet.com/journals/lanwp…

The Prevalence of #ChronicKidneyDisease in Australian #PrimaryCare: Analysis of a National General Practice Dataset #VisualAbstract by 💙🦋 Jade Teakell kireports.org/article/S2468-… Min Jun Brendon Neuen Sradha Kotwal Sunil Badve David Peiris Meg Jardine @[email protected] Vlado Perkovic The George Institute for Global Health

Kidney Function, Albuminuria and Risk of Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis buff.ly/3Q22tca Jeffrey Ha @jeffreyha.bsky.social Dearbhla Kelly Brendon Neuen Vlado Perkovic Min Jun @badves The George Institute for Global Health UNSW Medicine & Health #VisualAbstract

"I wanted to look into an area of research that had the biggest impact on society." Hear more from Nelson about his work on cardiovascular prevention and his long-term goals for his future work via Heart Foundation: buff.ly/3IaQNjK

Come work with us! We have an exciting opening for a biostatistician to join the The George Institute for Global Health's Renal & Metabolic Division Great opportunity to work on large-scale cardiorenal randomised trials and routinely collected data applynow.net.au/jobs/GEORGE694 DM me for details

Dr Sradha Kotwal of UNSW and The George Institute for Global Health has developed the Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect (CAPTIVATE), aiming to identify an effective drug to prevent CKD progression #KidneyHealthForAll #WorldKidneyDay